Angelini Pharma is a Rome-based pharmaceutical company and corporate strategic investor focused on life sciences, pharmaceuticals and brain health, including mental health and epilepsy. It has acted as a co-lead investor in later-stage U.S. therapeutics financing, making it most relevant for biotechnology and pharmaceutical founders seeking strategic pharma alignment, particularly in the United States.